Vanguard Group Inc. Buys 14,454 Shares of DocGo Inc. (NASDAQ:DCGO)

Vanguard Group Inc. grew its stake in shares of DocGo Inc. (NASDAQ:DCGO) by 0.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,014,375 shares of the company’s stock after buying an additional 14,454 shares during the quarter. Vanguard Group Inc. owned approximately 4.91% of DocGo worth $21,261,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. JPMorgan Chase & Co. grew its holdings in DocGo by 151.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock worth $365,000 after acquiring an additional 66,097 shares during the last quarter. Matrix Asset Advisors Inc. NY acquired a new position in shares of DocGo during the fourth quarter worth $424,000. Rhumbline Advisers grew its stake in shares of DocGo by 4.5% in the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock worth $605,000 after purchasing an additional 6,204 shares during the last quarter. WCM Investment Management LLC grew its stake in shares of DocGo by 64.2% in the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock worth $18,637,000 after purchasing an additional 1,687,100 shares during the last quarter. Finally, Harbor Capital Advisors Inc. raised its position in DocGo by 37.5% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock worth $5,647,000 after purchasing an additional 363,391 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Stock Performance

Shares of NASDAQ:DCGO opened at $2.25 on Wednesday. The firm has a market capitalization of $229.46 million, a PE ratio of 8.04, a price-to-earnings-growth ratio of 14.16 and a beta of 1.12. DocGo Inc. has a 52-week low of $2.16 and a 52-week high of $5.68. The firm has a fifty day moving average of $3.42 and a 200 day moving average of $3.82.

Analysts Set New Price Targets

A number of brokerages have commented on DCGO. Deutsche Bank Aktiengesellschaft cut shares of DocGo from a “buy” rating to a “hold” rating and cut their price target for the company from $5.00 to $2.85 in a research report on Friday, February 28th. Stifel Nicolaus cut their target price on DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $4.00 target price on shares of DocGo in a research note on Tuesday, April 8th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, DocGo currently has an average rating of “Moderate Buy” and an average target price of $4.89.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.